Cellectis (CLLS) Interest Expenses (2021 - 2026)

Cellectis (CLLS) recorded quarterly Interest Expenses of -$4.4 million in Q1 2026, down 104.9% quarter-over-quarter from $90.7 million in Q4 2025, and up 56.63% on a YoY basis from -$2.8 million in Q1 2025.

Cellectis (CLLS) Interest Expenses (2021 - 2026) Analysis & Trends

Cellectis' Interest Expenses history runs 6 years deep, the most recent figure standing at -$4.4 million for Q1 2026.

  • In Q1 2026, Interest Expenses rose 56.63% year-over-year to -$4.4 million; the TTM figure through Mar 2026 stood at $55.7 million (up 1555.4% YoY), while the FY2025 annual figure was $51.1 million, up 136.25% from the prior year.
  • Interest Expenses was -$4.4 million for Q1 2026 at Cellectis, down from $90.7 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $90.7 million in Q4 2025 to a low of -$19.7 million in Q2 2025.
  • Historically, Interest Expenses has averaged $6.7 million across 5 years, with a median of -$3.1 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Interest Expenses plunged 135700.0% in 2022, then jumped 190.28% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $22.0 million in 2022, then surged by 190.28% to $63.7 million in 2023, then slipped by 28.35% to $45.7 million in 2024, then surged by 98.68% to $90.7 million in 2025, then slumped by 104.9% to -$4.4 million in 2026.
  • The last three Interest Expenses figures came in at -$4.4 million (Q1 2026), $90.7 million (Q4 2025), and -$10.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -5.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -332,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 61,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -2,753.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -5.58 Mn
10 Cellectis 17.40 Bn 17.21 Bn - -4.44 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.44 Mn
Mar 31, 2026 -4.44 Mn
Dec 31, 2025 90.72 Mn
Dec 31, 2025 90.72 Mn
Sep 30, 2025 -10.91 Mn
Sep 30, 2025 -10.91 Mn
Jun 30, 2025 -19.70 Mn
Jun 30, 2025 -19.70 Mn
Mar 31, 2025 -10.25 Mn
Mar 31, 2025 -10.25 Mn
Dec 31, 2024 45.66 Mn
Dec 31, 2024 45.66 Mn
Sep 30, 2024 -15.41 Mn
Sep 30, 2024 -15.41 Mn
Jun 30, 2024 -16.65 Mn
Jun 30, 2024 -16.65 Mn
Mar 31, 2024 -3.14 Mn
Mar 31, 2024 -3.14 Mn
Dec 31, 2023 63.73 Mn
Dec 31, 2023 63.73 Mn